BIOLIFE SOLUTIONS INC (BLFS) › Cash & EquivalentsBIOLIFE SOLUTIONS INC (BLFS) — Cash & EquivalentsAnnual figures by fiscal year, from SEC filings.2009: $139.2K2010: $3.2K2011: $16.9K2012: $196.5K2013: $156.3K2014: $2.54M2015: $2.17M2016: $1.41M2017: $6.66M2018: $30.66M2019: $6.45M2020: $90.40M2021: $69.86M2022: $19.44M2023: $27.90M2024: $91.54M2025: $33.04M$33.04M2009Cash & Equivalents (USD)2025Fiscal YearCash & EquivalentsChange YoY2025$33.04M-63.9%2024$91.54M+228.1%2023$27.90M+43.5%2022$19.44M-72.2%2021$69.86M-22.7%2020$90.40M+1302.0%2019$6.45M-79.0%2018$30.66M+360.1%2017$6.66M+373.9%2016$1.41M-35.3%2015$2.17M-14.4%2014$2.54M+1524.6%2013$156.3K-20.5%2012$196.5K+1065.1%2011$16.9K+425.2%2010$3.2K-97.7%2009$139.2K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share